Timing of recurrent acute kidney injury is associated with mortality and chronic kidney disease progression in very elderly patients
Abstract
Acute kidney injury (AKI) recurrence is common in elderly patients, but whether the timing of recurrence influences clinical outcomes remains unknown. We hypothesized that early and late recurrence represent two distinct phenotypes with opposing outcomes—early recurrence being associated with short-term mortality, and late recurrence being associated with chronic kidney disease (CKD) progression. This multicenter retrospective cohort study included patients aged ≥ 75 years who recovered from an index AKI episode between January 2017 and December 2024. Recurrent AKI was defined as a new serum creatinine rise (≥ 26.5 µmol/L within 48 h or ≥ 50% within 7 days) after complete recovery from the preceding episode. Recurrence timing was categorized into four intervals: 8–14 days, 15–21 days, 22–28 days, and more than 28 days. Among 2,382 patients, 51.7% (1232/2382) experienced a second AKI episode. Recurrence occurred within 8–14 days in 10.4% (248/2382) of patients, within 15–21 days in 13.3% (316/2382), within 22–28 days in 13.8% (328/2382), and after 28 days in 13.2% (340/2382). Early recurrence (8–21 days) was characterized by acute severity markers (sepsis, mechanical ventilation, advanced AKI stage), whereas late recurrence (> 21 days) was characterized by chronic vulnerability markers (lower baseline eGFR, nephrotoxicity). New-onset CKD occurred in 17.1% (24/140) of those with early recurrence (8–14 days), rising to 36.3% (114/314) in those with late recurrence (> 28 days) ( P < 0.001). Compared with a single AKI episode, recurrence at any time window was independently associated with higher 90-day and 1-year mortality. The adjusted HRs for 90-day mortality were 7.826 (95% CI: 4.051–13.106) for 8–14 days, 5.965 (95% CI: 3.087–11.526) for 15–21 days, 4.484 (95% CI: 2.276–8.835) for 22–28 days, and 2.506 (95% CI: 1.206–5.204) for > 28 days; for 1-year mortality, the HRs were 2.713 (95% CI: 1.942–3.786), 2.654 (95% CI: 1.917–3.687), 1.965 (95% CI: 1.396–2.765), and 1.583 (95% CI: 1.108–2.264), respectively (all P < 0.01). AKI recurrence at any time window independently increases mortality. However, early recurrence (≤ 21 days) is independently associated with higher mortality, whereas late recurrence (> 21 days) is associated with higher CKD progression in descriptive analyses. Recurrence timing, not just frequency, may help guide post-discharge risk stratification and follow-up planning.
Related
- Interleukin-22 is associated with progression to acute-on-chronic liver failure and short-term mortality in cirrhosis
- Delayed Gastric Emptying Is Associated With Progression to End-Stage Renal Disease in Diabetic Patients With Chronic Upper Gastrointestinal Symptoms
- Outcomes of Revision Modified Broström Procedure with Periosteal Flap Augmentation in Patients with Recurrent Chronic Ankle Instability
- Development and validation of an interpretable machine learning model for early prediction of mortality in ICU patients with chronic obstructive pulmonary disease and heart failure
- Plasma Cystatin C as a Marker of Acute-on-Chronic Liver Failure and 28-Day Mortality in Patients With Acutely Decompensated Liver Cirrhosis: A Prospective Observational Study
BibTeX
@article{bai2026timing,
title = {{Timing of recurrent acute kidney injury is associated with mortality and chronic kidney disease progression in very elderly patients}},
author = {Yang Bai and Yan Wang and Xiaonan Ding and Qiang Lyu and Qiangguo Ao and Qinglin Li},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-74624-y},
url = {https://www.nature.com/articles/s41598-026-74624-y},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Timing of recurrent acute kidney injury is associated with mortality and chronic kidney disease progression in very elderly patients
AU - Yang Bai
AU - Yan Wang
AU - Xiaonan Ding
AU - Qiang Lyu
AU - Qiangguo Ao
AU - Qinglin Li
PY - 2026
DA - 2026/10/13
JO - Scientific Reports
DO - 10.1038/s41598-026-74624-y
UR - https://www.nature.com/articles/s41598-026-74624-y
AB - Acute kidney injury (AKI) recurrence is common in elderly patients, but whether the timing of recurrence influences clinical outcomes remains unknown. We hypothesized that early and late recurrence represent two distinct phenotypes with opposing outcomes—early recurrence being associated with short-term mortality, and late recurrence being associated with chronic kidney disease (CKD) progression. This multicenter retrospective cohort study included patients aged ≥ 75 years who recovered from an index AKI episode between January 2017 and December 2024. Recurrent AKI was defined as a new serum creatinine rise (≥ 26.5 µmol/L within 48 h or ≥ 50% within 7 days) after complete recovery from the preceding episode. Recurrence timing was categorized into four intervals: 8–14 days, 15–21 days, 22–28 days, and more than 28 days. Among 2,382 patients, 51.7% (1232/2382) experienced a second AKI episode. Recurrence occurred within 8–14 days in 10.4% (248/2382) of patients, within 15–21 days in 13.3% (316/2382), within 22–28 days in 13.8% (328/2382), and after 28 days in 13.2% (340/2382). Early recurrence (8–21 days) was characterized by acute severity markers (sepsis, mechanical ventilation, advanced AKI stage), whereas late recurrence (> 21 days) was characterized by chronic vulnerability markers (lower baseline eGFR, nephrotoxicity). New-onset CKD occurred in 17.1% (24/140) of those with early recurrence (8–14 days), rising to 36.3% (114/314) in those with late recurrence (> 28 days) ( P < 0.001). Compared with a single AKI episode, recurrence at any time window was independently associated with higher 90-day and 1-year mortality. The adjusted HRs for 90-day mortality were 7.826 (95% CI: 4.051–13.106) for 8–14 days, 5.965 (95% CI: 3.087–11.526) for 15–21 days, 4.484 (95% CI: 2.276–8.835) for 22–28 days, and 2.506 (95% CI: 1.206–5.204) for > 28 days; for 1-year mortality, the HRs were 2.713 (95% CI: 1.942–3.786), 2.654 (95% CI: 1.917–3.687), 1.965 (95% CI: 1.396–2.765), and 1.583 (95% CI: 1.108–2.264), respectively (all P < 0.01). AKI recurrence at any time window independently increases mortality. However, early recurrence (≤ 21 days) is independently associated with higher mortality, whereas late recurrence (> 21 days) is associated with higher CKD progression in descriptive analyses. Recurrence timing, not just frequency, may help guide post-discharge risk stratification and follow-up planning.
SN - 2045-2322
ER -